Samenvatting
The existing guidelines regarding the management of invasive pulmonary aspergillosis do not recommend screening of the extra-pulmonary sites. Due to the fact that the presence of central nervous system (CNS) aspergillosis will influence treatment decisions regarding which antifungal to use and the aimed target concentrations of azoles in plasma, to be informed about dissemination of the infection to the CNS is absolutely necessary. We demonstrate the need for a structured approach to screening of pediatric patients for CNS aspergillosis.
Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | 8-11 |
Aantal pagina's | 4 |
Tijdschrift | Medical Mycology Case Reports |
Volume | 4 |
Nummer van het tijdschrift | 1 |
DOI's | |
Status | Gepubliceerd - apr. 2014 |
Extern gepubliceerd | Ja |